The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)

Datos Bibliográficos

ID23366030
AutoresPaul E Greenberg (Analysis Group (United States), autor de correspondencia), Andrée-Anne Fournier (0000-0002-1601-0858, Analysis Group (United States)), Tammy Sisitsky (Analysis Group (United States)), Crystal T Pike, Crystal Pike (Analysis Group (United States)), R C Kessler (0000-0003-4831-2305, Harvard University)
Año2015
Volumen76
Número02
Páginas155-162
Fecha de publicación2015-02-25
Peer ReviewedSí
Open AccessNo
TipoARTICLE
RevistaThe Journal of Clinical Psychiatry (JOURNAL)
Identificadores de la revistaISSN: 0160-6689 • E-ISSN: 1534-8628
EditorialPhysicians Postgraduate Press, Inc (PUBLISHER)
DOI10.4088/jcp.14m09298
PMID25742202
OpenAlexW2039056175
IdiomaEN
Citas recibidas148
Referencias citadas11

BACKGROUND: The economic burden of depression in the United States--including major depressive disorder (MDD), bipolar disorder, and dysthymia--was estimated at $83.1 billion in 2000. We update these findings using recent data, focusing on MDD alone and accounting for comorbid physical and psychiatric disorders. METHOD: Using national survey (DSM-IV criteria) and administrative claims data (ICD-9 codes), we estimate the incremental economic burden of individuals with MDD as well as the share of these costs attributable to MDD, with attention to any changes that occurred between 2005 and 2010. RESULTS: The incremental economic burden of individuals with MDD increased by 21.5% (from $173.2 billion to $210.5 billion, inflation-adjusted dollars). The composition of these costs remained stable, with approximately 45% attributable to direct costs, 5% to suicide-related costs, and 50% to workplace costs. Only 38% of the total costs were due to MDD itself as opposed to comorbid conditions. CONCLUSIONS: Comorbid conditions account for the largest portion of the growing economic burden of MDD. Future research should analyze further these comorbidities as well as the relative importance of factors contributing to that growing burden. These include population growth, increase in MDD prevalence, increase in treatment cost per individual with MDD, changes in employment and treatment rates, as well as changes in the composition and quality of MDD treatment services.

Bipolar disorder · Comorbidity · Depression (economics) · Economic cost · Economics · Environmental health · Major depressive disorder · Mood · Population · Psychiatry · Quality of life (healthcare) · Bipolar Disorder and Treatment · Demography · Medicine · Mental Health Treatment and Access · Treatment of Major Depression